Skip to main content

Advertisement

SpringerLink
Log in

The Impact of Tunneled Catheters for Ascites and Peritoneal Carcinomatosis on Patient Rehospitalizations

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

The aim of the study is to assess patient outcomes, complications, impact on rehospitalizations, and healthcare costs in patients with malignant ascites treated with tunneled catheters.

Materials and Methods

A total of 84 patients with malignant ascites (mean age, 60 years) were treated with tunneled catheters. Patients with peritoneal carcinomatosis and malignant ascites treated with tunneled drain catheter placement over a 3-year period were studied. Overall survival from the time of ascites and catheter placement were stratified by primary cancer and analyzed using the Kaplan–Meier method. Complications were graded by the Common Terminology Criteria for Adverse Events v3.0 (CTCAE). The differences between pre- and post-catheter admissions, hospitalizations, and Emergency Department (ED) visits, as well as related inpatient expenses were compared using paired t tests.

Results

There were no significant differences in gender, age, or race between different primary cancer subgroups. One patient (1 %) developed bleeding (CTCAE-2). Four patients (5 %) developed local cellulitis (CTCAE-2). Three patients (4 %) had prolonged hospital stay (between 7 and 10 days) to manage ascites-related complications such as abdominal distention, discomfort, or pain. Comparison between pre- and post-catheter hospitalizations showed significantly lower admissions (−1.4/month, p < 0.001), hospital stays (−4.2/month, p = 0.003), and ED visits (−0.9/month, p = 0.002). The pre- and post-catheter treatment health care cost was estimated using MS-DRG IPPS payment system and it demonstrated significant cost savings from decreased inpatient admissions in post-treatment period (−$9535/month, p < 0.001).

Conclusions

Tunneled catheter treatment of malignant ascites is safe, feasible, well tolerated, and cost effective. Tunneled catheter treatment may play an important role in improving patients’ quality of life and outcomes while controlling health care expenditures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol. 2007;18:945–9.

    Article  CAS  PubMed  Google Scholar 

  2. Parsons SL, Lang MW, Steele RJ. Malignant ascites: a 2-year review from a teaching hospital. Eur J Surg Oncol. 1996;22:237–9.

    Article  CAS  PubMed  Google Scholar 

  3. Richard HM 3rd, Coldwell DM, Boyd-Kranis RL, Murthy R, Van Echo DA. Pleurx tunneled catheter in the management of malignant ascites. JVIR. 2001;12:373–5.

    Article  PubMed  Google Scholar 

  4. Sangisetty SL, Miner TJ. Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012;4:87–95.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Keen A, Fitzgerald D, Bryant A, Dickinson HO. Management of drainage for malignant ascites in gynaecological cancer. Cochrane Database Syst Rev. 2010;. doi:10.1002/14651858.CD007794.pub2.

    PubMed  PubMed Central  Google Scholar 

  6. Courtney A, Nemcek AA Jr, Rosenberg S, Tutton S, Darcy M, Gordon G. Prospective evaluation of the PleurX catheter when used to treat recurrent ascites associated with malignancy. JVIR. 2008;19:1723–31.

    Article  PubMed  Google Scholar 

  7. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258–66.

    Article  PubMed  Google Scholar 

  8. Pascual S, Such J, Perez-Mateo M. Spontaneous bacterial peritonitis and refractory ascites. Am J Gastroenterol. 2000;95:3686–7.

    Article  CAS  PubMed  Google Scholar 

  9. Iyengar TD, Herzog TJ. Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter. Am J Hosp Palliat Care. 2002;19:35–8.

    Article  PubMed  Google Scholar 

  10. De Gottardi A, Thevenot T, Spahr L, et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009;7:906–9.

    Article  PubMed  Google Scholar 

  11. Narayanan G, Pezeshkmehr A, Venkat S, Guerrero G, Barbery K. Safety and efficacy of the PleurX catheter for the treatment of malignant ascites. J Palliat Med. 2014;17:906–12.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Rosenberg S, Courtney A, Nemcek AA Jr, Omary RA. Comparison of percutaneous management techniques for recurrent malignant ascites. JVIR. 2004;15:1129–31.

    Article  PubMed  Google Scholar 

  13. Saiz-Mendiguren R, Gomez-Ayechu M, Noguera JJ, et al. Permanent tunneled drainage for malignant ascites: initial experience with the PleurX(R) catheter. Radiologia. 2010;52:541–5.

    Article  CAS  PubMed  Google Scholar 

  14. Tapping CR, Ling L, Razack A. PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success. Br J Radiol. 2012;85:623–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. White J, Carolan-Rees G. PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: a NICE Medical Technology Guidance. Appl Health Econ Health Policy. 2012;10:299–308.

    Article  PubMed  Google Scholar 

  16. Find A Code. http://www.findacode.com/. 2014.

  17. Lungren MP, Kim CY, Stewart JK, Smith TP, Miller MJ. Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. JVIR. 2013;24:1303–8.

    Article  PubMed  Google Scholar 

  18. McClellan M, McKethan AN, Lewis JL, Roski J, Fisher ES. A national strategy to put accountable care into practice. Health Aff (Proj Hope). 2010;29:982–90.

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Division of Interventional Radiology, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Chuanxing Qu, Anish Ghodadra, Kevin M. McCluskey, Ernesto Santos & Hyun S. Kim

  2. Division of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale Cancer Center, Yale University School of Medicine, 330 Cedar Street, TE 2-224, New Haven, CT, 06510, USA

    Minzhi Xing & Hyun S. Kim

  3. Yale Cancer Center, New Haven, CT, USA

    Hyun S. Kim

Authors
  1. Chuanxing Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Minzhi Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anish Ghodadra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kevin M. McCluskey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ernesto Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hyun S. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hyun S. Kim.

Ethics declarations

Conflict of Interest

All authors have no financial or other disclosures or relationship with any commercial organization that may have a direct or indirect interest in this manuscript.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qu, C., Xing, M., Ghodadra, A. et al. The Impact of Tunneled Catheters for Ascites and Peritoneal Carcinomatosis on Patient Rehospitalizations. Cardiovasc Intervent Radiol 39, 711–716 (2016). https://doi.org/10.1007/s00270-015-1258-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-015-1258-1

Keywords

Search

Navigation